# Equivariant spherical CNNs for accurate fiber orientation distribution estimation in neonatal diffusion MRI with reduced acquisition time

**Authors:** Haykel Snoussi, Davood Karimi

PMC · DOI: 10.3389/fnins.2025.1604545 · 2025-07-30

## TL;DR

This paper introduces a new neural network method for faster and more accurate brain imaging in newborns using reduced data.

## Contribution

A rotationally equivariant spherical CNN is proposed for neonatal dMRI with reduced acquisition time.

## Key findings

- The sCNN outperforms MLP baselines in FOD estimation accuracy across multiple metrics.
- FODs and tractography from sCNN are comparable to Hybrid-CSD ground truth using only 30% of data.
- The method enables faster and more cost-effective neonatal dMRI acquisitions.

## Abstract

Early and accurate assessment of brain microstructure using diffusion Magnetic Resonance Imaging (dMRI) is crucial for identifying neurodevelopmental disorders in neonates, but remains challenging due to low signal-to-noise ratio (SNR), motion artifacts, and ongoing myelination. In this study, we propose a rotationally equivariant Spherical Convolutional Neural Network (sCNN) framework tailored for neonatal dMRI. We predict the Fiber Orientation Distribution (FOD) from multi-shell dMRI signals acquired with a reduced set of gradient directions (30% of the full protocol), enabling faster and more cost-effective acquisitions. We train and evaluate the performance of our sCNN using real data from 43 neonatal dMRI datasets provided by the Developing Human Connectome Project (dHCP). Our results demonstrate that the sCNN significantly outperforms a Multi-Layer Perceptron (MLP) baseline across multiple quantitative metrics, including Mean Squared Error (MSE), Peak Signal-to-Noise Ratio (PSNR), Angular Correlation Coefficient (ACC), angular error, and peak match rate, indicating superior FOD estimation accuracy. More importantly, it yields FODs and tractography that are quantitatively comparable and qualitatively highly similar to those from a reliable Hybrid-CSD ground truth, despite using only 30% of the full acquisition data. These findings highlight sCNNs' potential for accurate and clinically efficient dMRI analysis, paving the way for improved diagnostic capabilities and characterization of early brain development with shorter scan times.

## Full-text entities

- **Genes:** CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}
- **Diseases:** anxiety (MESH:D001007), CSD (MESH:C562576), cerebral palsy (MESH:D002547), neurodevelopmental disorders (MESH:D002658), WM (MESH:D056784), FOD (MESH:D016773), neurodegenerative diseases (MESH:D019636), neurodevelopmental and neurological disorders (MESH:D009422)
- **Chemicals:** MRtrix3 (-), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343732/full.md

---
Source: https://tomesphere.com/paper/PMC12343732